A pan-European register-based observational study of abrocitinib and conventional systemic therapies in moderate and severe atopic dermatitis: the DREAM TO TREAT AD study protocol
一项基于泛欧洲注册登记的观察性研究，旨在评估阿布昔替尼与传统系统疗法在治疗中重度特应性皮炎中的疗效：DREAM TO TREAT AD 研究方案
期刊:Skin Health and Disease
影响因子:
doi:10.1093/skinhd/vzaf020
Gribaleva, Elizaveta; Krogh, Niels Steen; Prieto-Merino, David; Coker, Bolaji; Jackson, Abaigeal; Akkoc, Ahmet; Birkner, Thomas; Bruninx, Erwin; Hennessy, Con; Chan, Kaitlyn; Cutlar, Lara; Farrell, Byron; Fletcher, Godfrey; Gerbens, Louise; Frostrup, Anne Grete; Henrohn, Dan; Hyseni, Ariënna; Irvine, Alan D; Malek, Rayka; McCarthy, Caitriona; Vittrup, Ida; Ouwerkerk, Wouter; Randall, Rowena; Spuls, Phyllis I; Thomsen, Simon Francis; Wall, Dmitri; Weidinger, Stephan; Werfel, Thomas; Schmitt, Jochen; Flohr, Carsten
